Clinical trial Recruiting at 2 sites Phase 4 Interventional Ages 18 to 70

Using low-dose ketorolac to reduce opioid use in patients with multiple orthopedic injuries

Official title: Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients

Run by Massachusetts General Hospital · NCT06201676 · Data updated 2026-11-12

This study is testing if giving low-dose ketorolac to patients with multiple orthopedic injuries can help manage their pain and reduce the need for long-term opioid use.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment458 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations2 sites (Boston, Massachusetts and 1 other locations)
StatusRecruiting
StartedFebruary 28, 2025
Main results expectedDecember 31, 2026
Study endsAugust 31, 2027
Registry record updatedMay 14, 2026
Trial IDNCT06201676 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-70 with significant musculoskeletal trauma requiring surgical intervention and an anticipated hospital stay of at least five days.

Probably not a fit

Patients who are under 18 or over 70 years old, or those with certain medical conditions such as active gastrointestinal issues or chronic organ diseases, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates whether administering low-dose ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), during the first five days of hospitalization can reduce the likelihood of chronic opioid use in patients with orthopedic polytrauma. Participants will be randomly assigned to receive either ketorolac or a placebo, with pain and opioid use monitored daily. The study aims to determine the effectiveness of ketorolac in improving pain management and functional outcomes, as well as its potential to decrease long-term opioid dependence.

Why it matters

Potential benefit: If successful, this approach could significantly reduce chronic opioid use and improve pain management in orthopedic polytrauma patients.

How similar studies have gone: Previous studies have shown that short-term ketorolac treatment can effectively reduce acute pain and opioid use, suggesting potential success for this approach in preventing chronic opioid use.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient age: 18-70
* Patient or legally authorized representative (LAR) able to provide consent
* Patients with acute musculoskeletal trauma requiring surgical fixation (i.e. ORIF with plates and screws and/or intramedullary nailing)
* Anticipated hospital admission
* Patients who speak English or Spanish
* Patients who can be followed at the enrolling facility for at least 6 months

Exclusion Criteria:

* Patient age \< 18 or \> 70 years
* Patients with injury more than 24 hours prior to evaluation
* Patients with active hemorrhagic shock or risk of significant hemorrhage
* Patients who are pregnant or breastfeeding
* Patients with a history of active gastrointestinal bleeds or ulceration
* Patients with chronic use of steroids or immune-modulating drugs or history of organ transplantation
* Patients with preexisting chronic renal, liver, heart, or lung disease
* Patients with a creatinine ≥ 1.30 mg/dL during enrollment
* Patients with history of myocardial infarction, stroke, or bleeding disorder
* Patients with head or chest injury requiring surgical intervention
* Patients with allergy to ketorolac or hypersensitivity to aspirin
* Patients receiving chronic opioid therapy or treatment for opioid use disorder
* Patients who are current IV drug users
* Patients who require a daily NSAID or aspirin regimen, except for daily low-dose aspirin (81 mg)
* Patients with insufficient follow-up or anticipated difficulty in completing follow-up at a study site for a minimum of 6 months due to any of the follow reasons: death, no follow-up after initial discharge, severe psychiatric conditions, unstable living conditions, planned follow-up at another medical center not participating in this study, live far away from the clinic, and/or incarcerated

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Vanderbilt University Medical Center
    Nashville, Tennessee, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.